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observational, and 14% employed hybrid methods, including chart review or survey. 
Only 20% used independent observers. Three quarters (76%) reported descriptive 
statistics. Of 9 multi-centre studies, one used a random effects regression model to 
account for “centre clustering”, and 8 reported pooled data (3 of which used a “mean 
of centre averages” approach). Eleven studies (52%) compared two groups, of which 3 
applied an analytical design aiming to defect statistical differences, and 2 reported 
a sample size calculation. ConClusions: This review of T&M studies revealed that 
descriptive designs are most common (analytical designs using power calculations 
seem rare). Multi-centre comparator studies rarely use random effects regression 
models to account for “centre clustering”, though considered the method of choice 
to produce valid confidence intervals around point estimates. In general, statistical 
methodology is scarcely reported, affecting overall study credibility.
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objeCtives: Subgroup analyses of randomized trial data are performed to provide 
estimates of average treatment effects for patients with specific characteristics. They 
inform adoption and re-imbursement decisions by identifying groups of patients 
with favourable risk-benefit or cost-effectiveness ratios. They may also inform deci-
sions regarding the conduct and design of future clinical studies. However, subgroup 
analyses are essentially observational (patients are not randomized between sub-
groups) and there is a risk that the differences observed between subgroups may 
be due to chance rather than reflecting true effects. This risk is exacerbated as 
typically the same data are used to both select relevant subgroups and to estimate 
subgroups effects leading to biased estimates and underestimation of uncertainty. 
This tendency increases as the number of subgroups tested increases. A number of 
measures are recommended to reduce the risk of bias including: pre-specification, 
consideration of biological plausibility, and correction of inference for multiple 
testing. However, the risk of bias is not obviated by pre-specification, correction 
for multiplicity may lead to discounting of true subgroup effects, and biological 
plausibility may not be a particularly specific test. In addition, common cognitive 
and process biases associated with decision-making such as the action impera-
tive, optimism bias, anchoring, and group think may further lead to the inherent 
uncertainty in subgroup analyses to be effectively underestimated.  MetHoDs AnD 
Results: We demonstrate three techniques that may help to counteract these 
biases: graphical inference methods clearly illustrate the inherent uncertainty in 
subgroup analysis; Bayesian shrinkage estimation can reduce the effect of anchoring 
on the observed subgroup effects and encourage consideration of regression to the 
mean; and reframing exercises (for example, considering the credibility of biological 
plausibility arguments as if they had been mooted a priori) may counter optimism 
bias. ConClusions: These techniques are illustrated using a published subgroup 
analysis from the PLATO trial (NCT00391872)
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objeCtives: Along with uncertainty around the parameters and the initial param-
eter value assumptions used in health-economic evaluation models, an analy-
sis of the uncertainty around the model inputs/outputs is essential. Parameter 
importance analysis (PIA) provides an explicit framework to quantitatively iden-
tify the contribution of each uncertain input to the output uncertainty. There are 
several methods available to be used in PIA. The objectives of this research were 
to investigate different PIA methods with the pros and cons of each method and 
identify the most robust method with respect to different initial parameter value 
assumptions. MetHoDs: A health economic model for heart failure is developed 
to serve as a basis to implement different PIA methods. Six alternative methods 
are applied: One-way sensitivity analysis, rank correlation analysis, analysis of 
covariance (ANCOVA), dominance analysis, standardized regression analysis and 
expected value of perfect parameter information (EVPPI) analysis. Initial parameter 
assumptions are varied and the robustness of each method is assessed with respect 
to how close the parameter importance rankings are with different initial param-
eter assumptions. Results: Each technique/initial parameter values’ assumption 
combination generates a different ranking for the importance of the parameters that 
explain the uncertainty around the expected net monetary benefit with £20,000/
QALY. EVPPI is the most robust method with respect to different initial parameter 
assumptions. However it is the most demanding method in terms of computation 
time. On the opposite side, one-way sensitivity analysis is the least computation 
time demanding method; however the importance rankings are very susceptible 
to change with different initial assumptions. Other Monte-Carlo simulation based 
methods (e.g. ANCOVA, dominance, standardized regression and rank correlation 
analysis) are alternative PIA methods, which generate rather robust rankings with 
different initial parameter assumptions. These alternative methods require sub-
stantially less computation times compared to EVPPI with high consistency and 
robustness to different initial value assumptions.
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objeCtives: Treatment switching is an important problem in Health Technology 
Assessment (HTA), particularly in oncology, which can often bias trial results. 
Although a variety of statistical approaches have been advocated for adjusting 
trials subject to treatment switching these all assume that Individual Patient Data 
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objeCtives: A set of disease states for patients with schizophrenia was previ-
ously published using a statistical clustering method, applied to Positive and 
Negative Syndrome Scale (PANSS) data from US patients. While factor analyses of 
the PANSS have shown remarkable stability of the structure across international 
populations, it is unknown whether similar multidimensional disease states would 
also be stable. Using data from the European Schizophrenia Cohort (EuroSC), a 
2-year observational study in 1,208 schizophrenia patients, we examined the fac-
tor structure of the PANSS and identified disease states using the same clustering 
method as previously. MetHoDs: A principal component analysis (PCA) was con-
ducted using the Kaiser criterion and varimax rotation on PANSS items, followed 
by a k-means cluster analysis on PANSS scores for items most strongly correlated 
with the PCA domains. For each cluster, a level (low, moderate, high) was assigned 
to each domain based on the cluster centres values. Kappa statistics were used 
to measure the agreement in assignment between the published and the derived 
states sets. Results: Five factors accounting for 56% of total variance were obtained 
from the PCA (positive symptoms, negative symptoms, cognitive impairment, mood 
disorder, and hostility). As in the analysis of patients in the initial US study, rates 
of change in root mean squared distance became small after six clusters. When 
assigning the two sets of states based on levels of positive, negative, and cognitive 
impairment, the simple, Cicchetti-Allison, and Fleiss-Cohen weighted Kappa sta-
tistics (95% CI) were, 0.418 (0.401-0.435), 0.568 (0.553-0.584), and 0.692 (0.676-0.709), 
respectively. ConClusions: The factor structure, number of discrete states, and 
combinations of levels of symptoms in states were similar in US and European 
populations. Resulting moderate-to-substantial agreement in assignment suggests 
that disease states obtained using k-means clustering from the PANSS generalise 
across international populations.
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objeCtives: The use of subsequent therapies has the potential to confound assess-
ment of overall survival (OS) in oncology trials, in particular for trials in early lines 
of therapy and for malignancies with several registered or investigational treatment 
options. Standard intent-to-treat analysis is biased, since treatment choices are 
likely to be influenced by events associated with mortality risk, such as disease pro-
gression. We review and compare available statistical methods to obtain unbiased 
estimates of OS effects in presence of subsequent therapies. MetHoDs: Marginal 
structural modeling methods include inverse-probability of censoring weighting 
(IPCW) and inverse-probability of treatment weighting (IPTW). These methods 
explicitly model both treatment choices and effects of treatments on mortality. 
Rank-preserving structural failure time models (RPSFT) instead depend on paramet-
ric assumptions regarding the effect of investigational and subsequent therapies 
on survival, and require non-standard estimation methods such as G-estimation 
or iterative parameter estimation (IPE). We compare the results with the different 
methods with data from the Lux Lung 1 trial of the tyrosine kinase inhibitor afatinib 
in non-small cell lung cancer. Results: IPCW and IPTW require detailed informa-
tion on covariates that influence treatment choices and are sensitive to model 
misspecification. RPSFT may not yield a single estimate of treatment effects due 
to limitations of the G-estimation procedure. All methods were consistent with a 
potential OS benefit from afatinib, but the hazard ratio varied from 0.583 (p= 0.038) 
with the pre-specified IPCW method to 0.894 (0.281) with RPSFT/IPE. ConClusions: 
The proposed methods for obtaining unbiased OS estimates in presence of sub-
sequent therapies rest on assumptions that cannot be tested empirically. There 
is currently no accepted standard method; pre-specification of model choice is of 
importance as well as testing alternative methods. Care should be taken to avoid 
unbalance in subsequent therapy and to record specific information on adminis-
tered treatments with potential OS effects.
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objeCtives: To review design characteristics of T&M studies applied to health care, 
with a focus on choice of study design, statistical methodology, and handling of 
multi-centre data. MetHoDs: A PubMed search was performed using key search 
terms including “time and motion” (MeSH Term) AND any of the following: cost 
(analysis), (health) economics, observation(al), and prospective. Articles (English; 
2008 or later) were selected based on the following criteria: (1) observational study 
using T&M methodology; and (2) task-based data collection. Studies that measured 
broad aggregate health care professional tasks/hospital workflows, in the absence of 
task- or event-specific timings, were excluded. Results: Of 191 identified abstracts, 
151 were excluded during screening; upon review, 21 of 40 remaining were retained 
for detailed assessment. Half (48%) were applicable to Europe, of which 2 were 
multi-country studies. Medical interventions studied were: drug (48%), diagnostic 
process (14%), medical procedure (24%), and IT systems to improve clinical manage-
ment (e.g. EMR) (14%). The majority (86%) of studies were hospital-based, 86% were 
